Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1990 3
1997 1
1998 1
2000 1
2001 1
2004 1
2006 1
2007 1
2008 2
2011 1
2012 4
2013 1
2014 2
2015 1
2017 1
2019 2
2020 3
2021 1
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

28 results

Results by year

Filters applied: . Clear all
Page 1
Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA.
Liu MC, Oxnard GR, Klein EA, Swanton C, Seiden MV; CCGA Consortium. Liu MC, et al. Ann Oncol. 2020 Jun;31(6):745-759. doi: 10.1016/j.annonc.2020.02.011. Epub 2020 Mar 30. Ann Oncol. 2020. PMID: 33506766 Free PMC article.
Stage I-III sensitivity was 67.3% (CI: 60.7% to 73.3%) in a pre-specified set of 12 cancer types (anus, bladder, colon/rectum, esophagus, head and neck, liver/bile-duct, lung, lymphoma, ovary, pancreas, plasma cell neoplasm, stomach), which account for 63% of US can …
Stage I-III sensitivity was 67.3% (CI: 60.7% to 73.3%) in a pre-specified set of 12 cancer types (anus, bladder, colon/rectum, esophagus, he …
Primary Pulmonary Lymphomas.
Piña-Oviedo S, Weissferdt A, Kalhor N, Moran CA. Piña-Oviedo S, et al. Adv Anat Pathol. 2015 Nov;22(6):355-75. doi: 10.1097/PAP.0000000000000090. Adv Anat Pathol. 2015. PMID: 26452211 Review.
Primary lung lymphoma (PLL) is a rare disease that comprises <0.5% of all primary lung tumors. ...
Primary lung lymphoma (PLL) is a rare disease that comprises <0.5% of all primary lung tumors. ...
Primary lung lymphoma.
Vallisa D, Trabacchi E, Cavanna L. Vallisa D, et al. Curr Drug Targets Inflamm Allergy. 2004 Dec;3(4):469-71. doi: 10.2174/1568010042634550. Curr Drug Targets Inflamm Allergy. 2004. PMID: 15584896 Review.
Moreover, new clinical-pathological entities are responsible of primary lung lymphoma that require specific treatment. It is important to keep in mind the chance that lung may be involved by lymphoproliferative disorders so to avoid the mistake of the misdiagnosis o …
Moreover, new clinical-pathological entities are responsible of primary lung lymphoma that require specific treatment. It is i …
Forty years literature review of primary lung lymphoma.
Parissis H. Parissis H. J Cardiothorac Surg. 2011 Mar 3;6:23. doi: 10.1186/1749-8090-6-23. J Cardiothorac Surg. 2011. PMID: 21371331 Free PMC article. Review.
There are several unresolved issues through out the literature regarding the entity of primary lung lymphoma. Extensive literature review of this uncommon pathology is carried out. ...
There are several unresolved issues through out the literature regarding the entity of primary lung lymphoma. Extensive litera …
PET imaging in oncology.
Bar-Shalom R, Valdivia AY, Blaufox MD. Bar-Shalom R, et al. Semin Nucl Med. 2000 Jul;30(3):150-85. doi: 10.1053/snuc.2000.7439. Semin Nucl Med. 2000. PMID: 10928381 Review.
Perhaps the most striking development is the use of PET in oncology. PET imaging is approved in the United States for lung, lymphoma, colon, and melanoma cancer imaging. Data are accumulating rapidly to attest the efficacy of Fluorine-18 fluorodeoxyglucose (FDG) ima …
Perhaps the most striking development is the use of PET in oncology. PET imaging is approved in the United States for lung, lympho …
Impact of Oncology Drug Shortages on Chemotherapy Treatment.
Alpert A, Jacobson M. Alpert A, et al. Clin Pharmacol Ther. 2019 Aug;106(2):415-421. doi: 10.1002/cpt.1390. Epub 2019 Apr 8. Clin Pharmacol Ther. 2019. PMID: 30739322 Free PMC article.
Using Medicare claims linked to Surveillance Epidemiology and End Results (SEER), we examined outpatient chemotherapy use during shortage periods relative to the months before and after a shortage for newly diagnosed patients with breast, colorectal, leukemia, lung, lym …
Using Medicare claims linked to Surveillance Epidemiology and End Results (SEER), we examined outpatient chemotherapy use during shortage pe …
Overview of the clinical effectiveness of positron emission tomography imaging in selected cancers.
Facey K, Bradbury I, Laking G, Payne E. Facey K, et al. Health Technol Assess. 2007 Oct;11(44):iii-iv, xi-267. doi: 10.3310/hta11440. Health Technol Assess. 2007. PMID: 17999839 Free article. Review.
OBJECTIVES: To assess the clinical effectiveness of positron emission tomography (PET) using 2-[18F]-fluoro-2-deoxy-D-glucose (FDG) in breast, colorectal, head and neck, lung, lymphoma, melanoma, oesophageal and thyroid cancers. Management decisions relating to diag …
OBJECTIVES: To assess the clinical effectiveness of positron emission tomography (PET) using 2-[18F]-fluoro-2-deoxy-D-glucose (FDG) in breas …
Medical Service Use and Charges for Cancer Care in 2018 for Privately Insured Patients Younger Than 65 Years in the US.
Zaorsky NG, Khunsriraksakul C, Acri SL, Liu DJ, Ba DM, Lin JL, Liu G, Segel JE, Drabick JJ, Mackley HB, Leslie DL. Zaorsky NG, et al. JAMA Netw Open. 2021 Oct 1;4(10):e2127784. doi: 10.1001/jamanetworkopen.2021.27784. JAMA Netw Open. 2021. PMID: 34613403 Free PMC article.
CONCLUSIONS AND RELEVANCE: This analysis suggests that patients with breast, colorectal, and prostate cancers had the greatest number of services performed, particularly for pathology and laboratory tests, whereas patients with breast, lung, lymphoma, and colorectal …
CONCLUSIONS AND RELEVANCE: This analysis suggests that patients with breast, colorectal, and prostate cancers had the greatest number of ser …
Survival of older patients with cancer in the Veterans Health Administration versus fee-for-service Medicare.
Landrum MB, Keating NL, Lamont EB, Bozeman SR, Krasnow SH, Shulman L, Brown JR, Earle CC, Rabin M, McNeil BJ. Landrum MB, et al. J Clin Oncol. 2012 Apr 1;30(10):1072-9. doi: 10.1200/JCO.2011.35.6758. Epub 2012 Mar 5. J Clin Oncol. 2012. PMID: 22393093 Free PMC article.
PATIENTS AND METHODS: We used propensity-score methods to compare all-cause and cancer-specific survival rates for men older than age 65 years who were diagnosed or received their first course of treatment for colorectal, lung, lymphoma, or multiple myeloma in VHA h …
PATIENTS AND METHODS: We used propensity-score methods to compare all-cause and cancer-specific survival rates for men older than age 65 yea …
28 results